{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:16:52Z","timestamp":1769282212897,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rec.2024.03.013","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T22:14:02Z","timestamp":1714601642000},"page":"976-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants"],"prefix":"10.1016","volume":"77","author":[{"given":"Alberto","family":"Alperi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Ptaszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"del Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hern\u00e1ndez-Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Almend\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Antuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Lude\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Mor\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Avanzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2024.03.013_bib0125","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0135","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.recesp.2021.07.013","article-title":"Early clinical outcomes after transaxillary versus transfemoral TAVI Data from the Spanish TAVI registry","volume":"75","author":"Jim\u00e9nez-Quevedo","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.03.013_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.recesp.2021.05.014","article-title":"Cusp-overlapping TAVI technique with a self-expanding device optimizes implantation depth and reduces permanent pacemaker requirement","volume":"75","author":"Pascual","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.03.013_bib0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.03.013_bib0155","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0160","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/FJC.0000000000000129","article-title":"Meta-analysis of efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation","volume":"64","author":"Jia","year":"2014","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.rec.2024.03.013_bib0165","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVI","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0170","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: The valve academic research consortium-2 consensus document","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.03.013_bib0175","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.03.013_bib0180","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency Timing, and Impact of Access-Site and Non-Access-Site Bleeding on Mortality Among Patients Undergoing Transcatheter Aortic Valve Replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"J Am Coll Cardiol Intv."},{"key":"10.1016\/j.rec.2024.03.013_bib0185","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","article-title":"Bleeding Events After Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review","volume":"81","author":"Avvedimento","year":"2023","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.03.013_bib0190","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0195","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2018.08.2143","article-title":"Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement","volume":"72","author":"Kibler","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.03.013_bib0200","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.03.013_bib0205","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.03.013_bib0210","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.03.013_bib0215","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcin.2019.03.003","article-title":"Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement","volume":"12","author":"Jochheim","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.03.013_bib0220","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231158585","article-title":"Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis","volume":"29","author":"Lee","year":"2023","journal-title":"Clinical and Applied Thrombosis\/Hemostasis."},{"key":"10.1016\/j.rec.2024.03.013_bib0225","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcin.2021.05.025","article-title":"TAVI Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?","volume":"14","author":"Didier","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.03.013_bib0230","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation After TAVI","volume":"13","author":"Kawashima","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2024.03.013_bib0235","first-page":"279","article-title":"Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.03.013_bib0240","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.123.067312","article-title":"Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation","volume":"149","author":"Kapadia","year":"2024","journal-title":"Circulation."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724001464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724001464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:05:25Z","timestamp":1733857525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585724001464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1885585724001464"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2024.03.013","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.06.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2024.03.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}